Zeo ScientifiX Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Zeo ScientifiX's earnings have been declining at an average annual rate of -0.3%, while the Biotechs industry saw earnings growing at 19% annually. Revenues have been growing at an average rate of 16.5% per year.
Belangrijke informatie
-0.3%
Groei van de winst
14.3%
Groei van de winst per aandeel
Biotechs Groei van de industrie | 17.0% |
Inkomstengroei | 16.5% |
Rendement op eigen vermogen | n/a |
Nettomarge | -94.7% |
Laatste winstupdate | 31 Jul 2024 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe Zeo ScientifiX geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
31 Jul 24 | 5 | -5 | 9 | 0 |
30 Apr 24 | 5 | -5 | 9 | 0 |
31 Jan 24 | 5 | -6 | 10 | 0 |
31 Oct 23 | 5 | -7 | 11 | 0 |
31 Jul 23 | 5 | -9 | 13 | 0 |
30 Apr 23 | 5 | -10 | 14 | 0 |
31 Jan 23 | 6 | -10 | 15 | 0 |
31 Oct 22 | 6 | -9 | 15 | 0 |
31 Jul 22 | 7 | -7 | 13 | 0 |
30 Apr 22 | 6 | -6 | 12 | -1 |
31 Jan 22 | 6 | -6 | 12 | 0 |
31 Oct 21 | 6 | -13 | 18 | 0 |
31 Jul 21 | 5 | -17 | 21 | 0 |
30 Apr 21 | 4 | -21 | 24 | 1 |
31 Jan 21 | 4 | -20 | 23 | 0 |
31 Oct 20 | 3 | -13 | 15 | 0 |
31 Jul 20 | 3 | -8 | 10 | 0 |
30 Apr 20 | 2 | -3 | 5 | 0 |
31 Jan 20 | 2 | -2 | 4 | 0 |
31 Oct 19 | 2 | -2 | 3 | 0 |
31 Jul 19 | 1 | -1 | 4 | 0 |
30 Apr 19 | 1 | -1 | 2 | 0 |
31 Jan 19 | 1 | -4 | 5 | 0 |
31 Oct 18 | 1 | -3 | 5 | 0 |
31 Jul 18 | 1 | -4 | 5 | 0 |
30 Apr 18 | 1 | -5 | 6 | 0 |
31 Jan 18 | 1 | -5 | 6 | 0 |
31 Oct 17 | 1 | -9 | 9 | 0 |
31 Jul 17 | 0 | -8 | 8 | 0 |
30 Apr 17 | 0 | -8 | 8 | 0 |
31 Jan 17 | 0 | -5 | 5 | 0 |
31 Oct 16 | 0 | -1 | 1 | 0 |
31 Jul 16 | 0 | -1 | 1 | 0 |
30 Apr 16 | 0 | -1 | 1 | 0 |
31 Jan 16 | 0 | -1 | 1 | 0 |
31 Oct 15 | 0 | -1 | 1 | 0 |
31 Jul 15 | 0 | 0 | 0 | 0 |
30 Apr 15 | 0 | 0 | 0 | 0 |
31 Jan 15 | 0 | 0 | 0 | 0 |
31 Oct 14 | 0 | 0 | 0 | 0 |
31 Jul 14 | 0 | 0 | 0 | 0 |
30 Apr 14 | 0 | 0 | 0 | 0 |
31 Jan 14 | 0 | 0 | 0 | 0 |
Kwaliteitswinsten: ZEOX is currently unprofitable.
Groeiende winstmarge: ZEOX is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: ZEOX is unprofitable, and losses have increased over the past 5 years at a rate of 0.3% per year.
Versnelling van de groei: Unable to compare ZEOX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: ZEOX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-2.3%).
Rendement op eigen vermogen
Hoge ROE: ZEOX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.